Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BY-NC-NDEJHaem

Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report

  1. 1Eastern Health

Related

  1. Richter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape
    Juan Marquet-Palomanes, Fernando Martin-Moro, Jose A. Garcia-Vela
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Persistent SARS‐CoV‐2 RNA Positivity in a Chronic Lymphocytic Leukaemia Patient for 127 Days After Disease Onset: A Case Report
    Farnoosh Khamseh, Amir‐Hossein Moghtader‐Mojdehi, Zahra Nemati +1
    Respirology Case ReportsPeer-reviewedCC BYFull textInfectious diseaseDOAJ
  3. USP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival.
    Hassan N B Almuhanna, Jodie Hay, Michael W Moles +6
    Molecular oncologyPeer-reviewedCC BYFull textHuman geneticsEurope PMC
  4. Economic Burden of Chronic Lymphocytic Leukaemia in Australia
    Lan Gao, Dieu Nguyen, Victoria White +2
    European Journal of HaematologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  5. Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia—Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups
    Thérèse Aurran-Schleinitz, Rémi Letestu, Mary Sartor +43
    British Journal of HaematologyPeer-reviewedCC BY-NCFull textHuman geneticsHAL
BibTeX
@article{wei2026aplastic,
  title = {{Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report}},
  author = {Zachray Wei and Tamara Marconi and Lucy Tuck and Stephen Ting},
  journal = {EJHaem},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13652953},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report
AU  - Zachray Wei
AU  - Tamara Marconi
AU  - Lucy Tuck
AU  - Stephen Ting
PY  - 2026
DA  - 2026/10/01
JO  - EJHaem
UR  - https://europepmc.org/article/PMC/PMC13652953
SN  - 2688-6146
ER  -